219 related articles for article (PubMed ID: 18422601)
1. Single dose intravenous thioacetamide administration as a model of acute liver damage in rats.
Chen TM; Subeq YM; Lee RP; Chiou TW; Hsu BG
Int J Exp Pathol; 2008 Aug; 89(4):223-31. PubMed ID: 18422601
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the protective and therapeutic effect of melatonin against thioacetamide-induced acute liver damage.
Sayan M; Karabulut D; Özdamar S
J Biochem Mol Toxicol; 2020 Apr; 34(4):e22450. PubMed ID: 31967703
[TBL] [Abstract][Full Text] [Related]
3. Caffeine intake decreases oxidative stress and inflammatory biomarkers in experimental liver diseases induced by thioacetamide: Biochemical and histological study.
Amer MG; Mazen NF; Mohamed AM
Int J Immunopathol Pharmacol; 2017 Mar; 30(1):13-24. PubMed ID: 28281876
[TBL] [Abstract][Full Text] [Related]
4. The protection by heme oxygenase-1 induction against thioacetamide-induced liver toxicity is associated with changes in arginine and asymmetric dimethylarginine.
Develi-Is S; Bekpinar S; Kalaz EB; Evran B; Unlucerci Y; Gulluoglu M; Uysal M
Cell Biochem Funct; 2013 Mar; 31(2):122-8. PubMed ID: 22886620
[TBL] [Abstract][Full Text] [Related]
5. Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats.
Bruck R; Aeed H; Avni Y; Shirin H; Matas Z; Shahmurov M; Avinoach I; Zozulya G; Weizman N; Hochman A
J Hepatol; 2004 Jan; 40(1):86-93. PubMed ID: 14672618
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832
[TBL] [Abstract][Full Text] [Related]
7. Protective role of antioxidants on thioacetamide-induced acute hepatic encephalopathy: biochemical and ultrastructural study.
Mustafa HN; El Awdan SA; Hegazy GA
Tissue Cell; 2013 Oct; 45(5):350-62. PubMed ID: 23876406
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin reduces rhabdomyolysis-induced acute renal failure in rats.
Yang FL; Subeq YM; Chiu YH; Lee RP; Lee CJ; Hsu BG
Injury; 2012 Mar; 43(3):367-73. PubMed ID: 22209169
[TBL] [Abstract][Full Text] [Related]
9. Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats.
Murad HA; Gazzaz ZJ; Ali SS; Ibraheem MS
Braz J Med Biol Res; 2017 Sep; 50(11):e6665. PubMed ID: 28953991
[TBL] [Abstract][Full Text] [Related]
10. BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats.
Lu L; Wu C; Lu BJ; Xie D; Wang Z; Bahaji Azami NL; An YT; Wang HJ; Ye G; Sun MY
J Ethnopharmacol; 2020 Mar; 249():112301. PubMed ID: 31622746
[TBL] [Abstract][Full Text] [Related]
11. Preventive effects of Ophiocordyceps sinensis mycelium on the liver fibrosis induced by thioacetamide.
Wu YS; Tseng JK; Chou CH; Chiu CH; Lin YL; Chen YC
Environ Toxicol; 2017 Jun; 32(6):1792-1800. PubMed ID: 28181416
[TBL] [Abstract][Full Text] [Related]
12. Allopurinol ameliorates thioacetamide-induced acute liver failure by regulating cellular redox-sensitive transcription factors in rats.
Demirel U; Yalniz M; Aygün C; Orhan C; Tuzcu M; Sahin K; Ozercan IH; Bahçecioğlu IH
Inflammation; 2012 Aug; 35(4):1549-57. PubMed ID: 22535497
[TBL] [Abstract][Full Text] [Related]
13. Hepatic stimulator substance activity in the liver of thioacetamide-intoxicated rats.
Margeli AP; Skaltsas SD; Spiliopoulou CA; Mykoniatis MG; Theocharis SE
Liver; 1999 Dec; 19(6):519-25. PubMed ID: 10661686
[TBL] [Abstract][Full Text] [Related]
14. An antibody of TNF-alpha did not prevent thioacetamide-induced hepatotoxicity in rats.
Demirel U; Harputluoglu MM; Seckin Y; Ciralik H; Temel I; Ozyalin F; Otlu B; Yilmaz B; Dincturk MS; Aladag H
Hum Exp Toxicol; 2011 Jul; 30(7):560-6. PubMed ID: 20534638
[TBL] [Abstract][Full Text] [Related]
15. Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis.
Shaker ME; Shiha GE; Ibrahim TM
Eur J Pharmacol; 2011 Nov; 670(2-3):593-600. PubMed ID: 21925495
[TBL] [Abstract][Full Text] [Related]
16. Potential Effect of 1,25 Dihydroxyvitamin D
Özdemir-Kumral ZN; Erkek BE; Karakuş B; Almacı M; Fathi R; Yüksel M; Cumbul A; Alican İ
J Surg Res; 2019 Nov; 243():165-172. PubMed ID: 31177036
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of thioacetamide hepatotoxicity by phenobarbital pretreatment in rats. Inducibility of FAD monooxygenase system and age effect.
Zaragoza A; Andrés D; Sarrión D; Cascales M
Chem Biol Interact; 2000 Jan; 124(2):87-101. PubMed ID: 10670821
[TBL] [Abstract][Full Text] [Related]
18. Effect of hepatic stimulator substance administration on tissue regeneration due to thioacetamide-induced liver injury in rats.
Theocharis SE; Margeli AP; Agapitos EV; Mykoniatis MG; Kittas CN; Davaris PS
Scand J Gastroenterol; 1998 Jun; 33(6):656-63. PubMed ID: 9669640
[TBL] [Abstract][Full Text] [Related]
19. Is rat liver affected by non-alcoholic steatosis more susceptible to the acute toxic effect of thioacetamide?
Kučera O; Lotková H; Staňková P; Podhola M; Roušar T; Mezera V; Cervinková Z
Int J Exp Pathol; 2011 Aug; 92(4):281-9. PubMed ID: 21410800
[TBL] [Abstract][Full Text] [Related]
20. Effects of armepavine against hepatic fibrosis induced by thioacetamide in rats.
Weng TC; Shen CC; Chiu YT; Lin YL; Huang YT
Phytother Res; 2012 Mar; 26(3):344-53. PubMed ID: 21717514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
